Special Issue "Tropical Medicine"
A special issue of Pharmaceuticals (ISSN 1424-8247).
Deadline for manuscript submissions: closed (31 January 2010)
Prof. Dr. Peter A. Leggat
Head of School of Public Health, Tropical Medicine and Rehabilitation Sciences, Faculty of Medicine, Health and Molecular Sciences James Cook University, Townsville Qld 4811, Australia
All papers should be submitted to firstname.lastname@example.org. To be published continuously until the deadline and papers will be listed together at the special issue website.
Submitted papers should not have been published nor be under consideration for publication elsewhere. All papers are refereed through a peer-review process. A guide for authors is available on the Instructions for Authors page. Pharmaceuticals is a new international, peer-reviewed, quarterly open access journal published by MDPI.
Article Processing Charges (APC) for publication in this open access journal are waived for well-prepared manuscripts submitted by 30 June 2010. English correction or formatting fees of 250 CHF (Swiss Francs) will be charged in certain cases for those paper accepted for publication, that require extensive additional formatting and/or English corrections.
- Tropical medicine
- Tropical diseases
- Neglected tropical diseases
- Infectious diseases
- International health
Review: Synthetic Medicinal Chemistry in Chagas’ Disease: Compounds at The Final Stage of “Hit-To-Lead” Phase
Pharmaceuticals 2010, 3(4), 810-838; doi:10.3390/ph3040810
Received: 1 February 2010; in revised form: 15 March 2010 / Accepted: 19 March 2010 / Published: 25 March 2010| Download PDF Full-text (638 KB) | Download XML Full-text
Review: The Treatment of Melioidosis
Pharmaceuticals 2010, 3(5), 1296-1303; doi:10.3390/ph3051296
Received: 19 January 2010; in revised form: 29 March 2010 / Accepted: 20 April 2010 / Published: 27 April 2010| Download PDF Full-text (102 KB) | Download XML Full-text
Pharmaceuticals 2010, 3(5), 1561-1575; doi:10.3390/ph3051561
Received: 8 April 2010; in revised form: 28 April 2010 / Accepted: 10 May 2010 / Published: 18 May 2010| Download PDF Full-text (73 KB) | Download XML Full-text
Pharmaceuticals 2010, 3(10), 3212-3239; doi:10.3390/ph3103212
Received: 1 September 2010; in revised form: 7 October 2010 / Accepted: 11 October 2010 / Published: 13 October 2010| Download PDF Full-text (202 KB)
The below list represents only planned manuscripts. Some of these manuscripts have not been received by the Editorial Office yet. Papers submitted to MDPI journals are subject to peer-review.
Manuscript ID: Pharmceuticals-tropmed-20090725-Moro-us
Type of Paper: Review
Authors: Pedro L. Moro 1 and Peter M. Schantz 2
Affiliations: 1 Immunization Safety Office, Centers for Disease Control and Prevention, Atlanta, GA, USA; Email: email@example.com
2 Formerly with the Division of Parasitic Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA
Abstract: Echinococcosis (hydatid disease) is the infection of humans and animals by the larval stages of taeniid cestodes of the genus Echinococcus. Five species have been recognized, Echinococcus granulosus, E. multilocularis, E. vogeli, E. oligarthus, and E. shiquicus, but the first three are of public health importance. This review covers aspects of the biology, etiology, epidemiology, transmission, clinical features of the Echinococcus organisms, and recent advances in diagnosis and treatment of the diseases they cause. Despite progress achieved in the control of echinococcosis in certain areas, this zoonosis continues to be a major public health problem in many countries.
Last update: 18 May 2010